Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
RedactPHI
HIPAA-Compliant PHI Redaction
DetectICD10CM
ICD-10-CM Code Detection
Log in Register free account
1 code page views remaining. Guest accounts are limited to 1 page view. Register free account to get 5 more views.
Log in Register free account

Official Description

Blood count; platelet, automated

© Copyright 2025 American Medical Association. All rights reserved.

Common Language Description

An automated platelet count, designated by CPT® Code 85049, is a laboratory procedure that quantifies the number of platelets in a blood sample. Platelets, or thrombocytes, are small cell fragments in the blood that play a crucial role in the clotting process, helping to prevent excessive bleeding when injuries occur. This procedure is essential for diagnosing various medical conditions, particularly bleeding disorders such as von Willebrand disease, which affects the blood's ability to clot properly. Additionally, it is utilized in the evaluation of bone marrow diseases, including leukemia and other hematological malignancies. The automated platelet count is particularly important for monitoring patients who have undergone bone marrow transplants, are receiving chemotherapy, or suffer from chronic kidney disease or autoimmune disorders, as these conditions can significantly impact platelet production and function. The counting of platelets is performed using sophisticated automated devices that provide accurate and efficient results, ensuring timely diagnosis and management of the aforementioned conditions.

© Copyright 2025 Coding Ahead. All rights reserved.

1. Indications

The automated platelet count is indicated for several clinical scenarios, particularly when there is a suspicion of disorders affecting platelet levels or function. The following conditions may warrant this procedure:

  • Bleeding Disorders - Conditions such as von Willebrand disease, which can lead to abnormal bleeding due to insufficient clotting factors.
  • Bone Marrow Diseases - Disorders like leukemia and other blood cancers that can disrupt normal blood cell production, including platelets.
  • Monitoring Post-Transplant - Patients who have undergone bone marrow transplants require regular monitoring of platelet levels to assess recovery and detect potential complications.
  • Chemotherapy Patients - Individuals receiving chemotherapy may experience fluctuations in platelet counts due to the effects of treatment on bone marrow function.
  • Chronic Kidney Disease - Patients with chronic kidney disease may have altered platelet function and levels, necessitating regular assessment.
  • Autoimmune Disorders - Conditions that affect the immune system can also impact platelet counts, making monitoring essential.

2. Procedure

The automated platelet count procedure involves several key steps to ensure accurate measurement of platelet levels in the blood. The following outlines the procedural steps:

  • Step 1: Sample Collection - A blood sample is collected from the patient, typically via venipuncture, using a sterile technique to prevent contamination and ensure the integrity of the sample.
  • Step 2: Sample Preparation - The collected blood sample is prepared for analysis, which may involve mixing with anticoagulants to prevent clotting before testing.
  • Step 3: Automated Analysis - The prepared sample is then placed into an automated hematology analyzer. This device uses electronic methods to count the number of platelets present in the blood sample, providing rapid and precise results.
  • Step 4: Result Interpretation - The results from the automated analyzer are reviewed by laboratory personnel, who ensure that the data is accurate and complete before reporting it to the requesting physician.

3. Post-Procedure

After the automated platelet count is performed, the results are typically available within a short timeframe, allowing for prompt clinical decision-making. There are generally no specific post-procedure care requirements for patients, as the procedure is minimally invasive and does not involve any significant risks. However, it is essential for healthcare providers to interpret the results in the context of the patient's overall clinical picture, considering any symptoms or underlying conditions that may affect platelet levels. Follow-up testing may be necessary based on the initial findings, particularly if abnormal platelet counts are detected.

Short Descr AUTOMATED PLATELET COUNT
Medium Descr BLOOD COUNT PLATELET AUTOMATED
Long Descr Blood count; platelet, automated
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1D - Lab tests - blood counts
MUE 2
CCS Clinical Classification 233 - Laboratory - Chemistry and Hematology
59 Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25.
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
GZ Item or service expected to be denied as not reasonable and necessary
GA Waiver of liability statement issued as required by payer policy, individual case
XU Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service
X5 Diagnostic services requested by another clinician: for reporting services by a clinician who furnishes care to the patient only as requested by another clinician or subsequent and related services requested by another clinician; this modifier is reported for patient relationships that may not be adequately captured by the above alternative categories; reporting clinician service examples include but are not limited to, the radiologist's interpretation of an imaging study requested by another clinician
Q1 Routine clinical service provided in a clinical research study that is in an approved clinical research study
XS Separate structure, a service that is distinct because it was performed on a separate organ/structure
GW Service not related to the hospice patient's terminal condition
76 Repeat procedure or service by same physician or other qualified health care professional: it may be necessary to indicate that a procedure or service was repeated by the same physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 76 to the repeated procedure or service. note: this modifier should not be appended to an e/m service.
91 Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient.
GV Attending physician not employed or paid under arrangement by the patient's hospice provider
GX Notice of liability issued, voluntary under payer policy
GY Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit
Q0 Investigational clinical service provided in a clinical research study that is in an approved clinical research study
Q4 Service for ordering/referring physician qualifies as a service exemption
XE Separate encounter, a service that is distinct because it occurred during a separate encounter
Date
Action
Notes
2003-01-01 Added First appearance in code book in 2003.
Code
Description
Code
Description
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"